These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3666115)

  • 1. [Pharmacokinetic characteristics of ethacizine in patients with disorders of heart rhythm].
    Gneushev ET; Kurapov AP; Beliakova GA; Zagrebin SV; Starodubtsev AK
    Farmakol Toksikol; 1987; 50(4):42-4. PubMed ID: 3666115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical effectiveness of ethacizine in various methods of intravenous administration].
    Lazutin VK; Simonov VI; Glezer MG; Fonsova EA; Khapilin PA
    Kardiologiia; 1988 Feb; 28(2):52-5. PubMed ID: 3286961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of ethacizine in tablet form in the treatment of arrhythmias].
    Lozinskiĭ LG; Sandomirskiĭ BL; Maksimova LN; Mutin SS
    Klin Med (Mosk); 1988 Nov; 66(11):50-5. PubMed ID: 3236807
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical pharmacokinetics and hemodynamics of ethacizin in the acute period of myocardial infarct].
    Beloborodov VL; Klimov AV; Tiukavkina NA; Kaverina NV; Pokazeeva ET
    Farmakol Toksikol; 1986; 49(5):32-6. PubMed ID: 3770172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pharmacodynamics and pharmacokinetics of bonnecor in patients with different disorders of the heart rhythm].
    Lozinskiĭ LG; Zamotaev IP; Zeltyn'-Abramov EM; Orlov VA; Beloborodov VL; Kosilova EE; Zalesskaia MA; Tiukavkina NA
    Farmakol Toksikol; 1990; 53(3):61-3. PubMed ID: 2387386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacodynamics and the pharmacokinetic parameters of etmozin in ventricular heart rhythm disorders].
    Kurbanov RD; Mazur NA; Piotrovskiĭ VK
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1982; 5(2):55-8. PubMed ID: 6182893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The characteristics of the action of ethacizine and its combination with digoxin and glutamic acid on the hemodynamic indices and myocardial contractile capacity in patients with a heart rhythm disorder].
    Zapevina VV; Poliakova LA; Nikolaeva SA
    Ter Arkh; 1990; 62(9):51-4. PubMed ID: 1980753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ethacizine on the chronic stimulation threshold].
    Kostyleva OV; Votchal FB; Grigorov SS
    Kardiologiia; 1989 Jun; 29(6):105-7. PubMed ID: 2779065
    [No Abstract]   [Full Text] [Related]  

  • 9. The pharmacology and clinical use of lidocaine as an antiarrhythmic drug--1972.
    Harrison DC; Alderman EL
    Mod Treat; 1972 Feb; 9(1):139-75. PubMed ID: 4555217
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arrhythmogenic effect of intravenous administration of ethacizine].
    Popov SV; Antonchenko IV; Gimrikh EO; Chekhov AM; Savenkova GM; Mitiutnev AN
    Kardiologiia; 1990 May; 30(5):75-8. PubMed ID: 2391817
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of intravenous administration of an anti-arrhythmia preparation ethacizine].
    Sandomirskiĭ BL; Lozinskiĭ LG
    Klin Med (Mosk); 1987 May; 65(5):51-6. PubMed ID: 3302525
    [No Abstract]   [Full Text] [Related]  

  • 12. [The combined effect of 2 first-line anti-arrhythmia drugs on the conduction velocity of myocardial stimulation].
    Nesterenko VV; Aniukhovskiĭ EP; Starmer ChF; Beloshapko GG; Ivanovich T; Bugriĭ EM; Mazaev AV; Rozenshtraukh LV
    Kardiologiia; 1990 Mar; 30(3):81-7. PubMed ID: 2381129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal].
    Karaush AP; Gorgaslidze AG; Smetnev AS
    Kardiologiia; 1991 Jan; 31(1):65-6. PubMed ID: 1710680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of ethacizine on the heart conduction system and the indicators of central hemodynamics].
    Gorshkov VA; Nesvetov VN; Kesarev GV; Sherashov VS; Mamaev VI
    Sov Med; 1991; (8):9-11. PubMed ID: 1763379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amiodarone absorption and elimination after oral and intravenous administration in healthy individuals].
    Gaete LE; Ortiz M; Soto J; Saavedra I
    Rev Med Chil; 1995 Jun; 123(6):713-9. PubMed ID: 8525224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Méxiletine. Action on heart rhythm disorders].
    Lellouche D; Bougherbal R
    Nouv Presse Med; 1975 Feb; 4(5):351-2. PubMed ID: 1093125
    [No Abstract]   [Full Text] [Related]  

  • 17. [Main pharmacokinetic parameters of p-tyrosol after intravenous injection in rats. Part III: Distribution of p-tyrosol in rat].
    Chernyshova GA; Plotnikov MB; Smol'iakova VI; Krasnov EA
    Eksp Klin Farmakol; 2011; 74(7):27-9. PubMed ID: 21894765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience using ethacizine in myocardial infarct patients].
    Kukes VG; Ponomarenko EL; Starodubtsev AK
    Kardiologiia; 1987 May; 27(5):97-8. PubMed ID: 2443746
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta blockers in acute myocardial infarction.
    Jariwala PV; Lathi P; Ramesh G; Saha D; Chandra KS
    Indian Heart J; 2010; 62(2):148-53. PubMed ID: 21180308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of ethmozine on ventricular rhythm disorders during the course of the early and late phases of myocardial infarcts].
    Rozenshtraukh LV; Ver'e RL; Laun B
    Vestn Akad Med Nauk SSSR; 1978; (10):52-7. PubMed ID: 706721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.